{
  "ticker": "JNJ",
  "target_date": "2025-03-18",
  "actual_date": "2025-03-18",
  "collected_at": "2025-12-08T11:31:48.689840",
  "price": {
    "open": 159.86,
    "high": 161.24,
    "low": 159.4,
    "close": 160.64723205566406,
    "volume": 7348800,
    "change_1d_pct": 0.87,
    "change_7d_pct": -1.46,
    "change_30d_pct": 9.02
  },
  "technicals": {
    "rsi_14": 53.76,
    "sma_20": 160.46,
    "sma_50": 151.43,
    "macd": 2.434,
    "macd_signal": 3.242,
    "macd_histogram": -0.808,
    "bb_upper": 165.21,
    "bb_lower": 155.71,
    "price_vs_sma20_pct": 0.12,
    "price_vs_sma50_pct": 6.09,
    "volume_ratio": 0.77
  },
  "fundamentals": {
    "market_cap": 489086910464,
    "pe_ratio": 19.594595,
    "forward_pe": 19.150942,
    "price_to_book": 6.161411,
    "price_to_sales": 5.307566,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.31,
    "pct_from_52w_low": 44.3
  },
  "macro": {
    "spy": {
      "price": 556.15,
      "change_1d_pct": -1.08,
      "change_7d_pct": 0.08
    },
    "vix": {
      "level": 21.7,
      "signal": "ELEVATED"
    },
    "treasury_10y": {
      "yield_pct": 4.28
    },
    "dollar_index": {
      "level": 103.24
    },
    "gold": {
      "price": 3035.1
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific",
      "source": "Yahoo",
      "datetime": 1742331660,
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Johnson & Johnson (JNJ) and Thermo Fisher Scientific Inc. (TMO), as well as a micro-cap stock AMREP Corporation (AXR).",
      "url": "https://finnhub.io/api/news?id=c3a23463b46a74763eb3bd9946d77cac989a1622acba0aa4008ee0bcf2c0d360"
    },
    {
      "headline": "Widely used drugs on US imports list from Europe",
      "source": "Finnhub",
      "datetime": 1742302715,
      "summary": "Widely used prescription medicinescould get caught up in the Trump administration's tariff tradewars and EU retaliation. The following is a list of major prescription drugs whoseingredients or...",
      "url": "https://finnhub.io/api/news?id=5617036b8ae429edb8be7dde9faf3243803fda284089ad99aabde775d98f0002"
    },
    {
      "headline": "Nipocalimab, the first and only investigational treatment to be granted U.S. FDA Breakthrough Therapy designation for the treatment of adults with moderate-to-severe Sj\u00f6gren's disease, has now receive",
      "source": "Finnhub",
      "datetime": 1742285046,
      "summary": "Sj\u00f6gren's disease \u00a0is a prevalent, debilitating autoantibody disease with no FDA-approved advanced treatments\u00a0\u00a0The Company is actively enrolling patients in the Phase 3 DAFFODIL study\u00a0\u00a0This...",
      "url": "https://finnhub.io/api/news?id=872e6b107c9821efa80789aeb1e22a52087063aab4c858fb49d690efde70049c"
    },
    {
      "headline": "Why Organon Is A Top Pick For Income Investors",
      "source": "SeekingAlpha",
      "datetime": 1742252303,
      "summary": "In mid-Feb., Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for income-oriented investors.",
      "url": "https://finnhub.io/api/news?id=697fea97f771736843602e4ccd567ee09566458d477be611dbdde99159b46b96"
    },
    {
      "headline": "Kenvue + Johnson & Johnson: I Choose To Own The Whole 'Humpty Dumpty'",
      "source": "SeekingAlpha",
      "datetime": 1742132403,
      "summary": "Discover why Johnson & Johnson and Kenvue offer resilient defensive stocks with high dividends.",
      "url": "https://finnhub.io/api/news?id=0e2a33e42c67c50b9950b3dc91a0d5278a086f640ec0823eadf61648f4b4a945"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297319.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000095/xslF345X05/wk-form4_1741297319.xml"
    },
    {
      "form": "4",
      "date": "2025-03-06",
      "description": "xslF345X05/wk-form4_1741297124.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000093/xslF345X05/wk-form4_1741297124.xml"
    },
    {
      "form": "4",
      "date": "2025-02-26",
      "description": "xslF345X05/wk-form4_1740613359.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000086/xslF345X05/wk-form4_1740613359.xml"
    },
    {
      "form": "8-K",
      "date": "2025-02-26",
      "description": "d863514d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525036773/d863514d8k.htm"
    },
    {
      "form": "8-K",
      "date": "2025-02-20",
      "description": "d866332d8k.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000119312525030851/d866332d8k.htm"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}